Valneva SE (VALN) Non-cash Items (2021 - 2025)
Valneva SE (VALN) posted quarterly Non-cash Items of $11.7 million for Q1 2025, down 31.91% year-on-year from $17.2 million in Q1 2024, and down 55.97% on a QoQ basis from $26.5 million in Q4 2024.
Valneva SE (VALN) Non-cash Items (2021 - 2025) Analysis & Trends
Valneva SE (VALN) has reported Non-cash Items for 5 consecutive years, with $11.7 million the latest figure, recorded in Q1 2025.
- Quarterly Non-cash Items fell 31.91% year-over-year to $11.7 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $50.3 million (down 14.43% YoY) and the FY2024 annual result came in at $55.7 million, up 8.88% from the prior year.
- Non-cash Items eased to $11.7 million in Q1 2025 per VALN's latest filing, from $26.5 million in the prior quarter.
- Over the last five years, Non-cash Items for VALN reached as high as $27.3 billion in Q2 2024 and fell as low as -$27.3 billion in Q3 2024.
- A 5-year average of $13.7 million and a median of $14.3 million in 2022 frame the typical range for Non-cash Items.
- The largest YoY upside for Non-cash Items was 101174.81% in 2023 against a maximum downside of 105269.95% in 2023.
- Year by year, Non-cash Items stood at $24.6 million in 2021, then rose by 21.55% to $29.9 million in 2022, then tumbled by 31.08% to $20.6 million in 2023, then gained by 28.65% to $26.5 million in 2024, then plunged by 55.97% to $11.7 million in 2025.
- According to Business Quant data, Non-cash Items over the past three periods registered $11.7 million, $26.5 million, and -$27.3 billion for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 11.68 Mn |
| Mar 31, 2025 | 11.68 Mn |
| Dec 31, 2024 | 26.52 Mn |
| Dec 31, 2024 | 26.52 Mn |
| Sep 30, 2024 | -27.25 Bn |
| Sep 30, 2024 | -27.25 Bn |
| Jun 30, 2024 | 27.26 Bn |
| Jun 30, 2024 | 27.26 Bn |
| Mar 31, 2024 | 17.15 Mn |
| Mar 31, 2024 | 17.15 Mn |
| Dec 31, 2023 | 20.62 Mn |
| Dec 31, 2023 | 20.62 Mn |
| Sep 30, 2023 | -14.49 Bn |
| Sep 30, 2023 | -14.49 Bn |
| Jun 30, 2023 | 14.52 Bn |
| Jun 30, 2023 | 14.52 Bn |
| Mar 31, 2023 | 9.60 Mn |
| Mar 31, 2023 | 9.60 Mn |
| Dec 31, 2022 | 29.91 Mn |
| Dec 31, 2022 | 29.91 Mn |